Landing Page graphic QuantideX RNA Lung 1000x500Asuragen introduces our latest NGS-in-a-Box assay product for analysis of fusion and exon skipping events important to NSCLC diseases –
QuantideX® NGS RNA Lung Cancer Kit (RUO)

Major Highlights & Advantages

  • Asuragen’s industry-first NGS-in-a-Box™ assay kits are uniquely configured for an end-to-end (sample-to-data) NGS workflow:
    • All sequencing library preparation materials and reagents
    • Data analysis solution
  • Highly efficient workflowHands-on time ~2.25h (24 samples)
    • Sample indexing ≥48 per MiSeq flowcell (v3 kit)
    • Optimized to handle low RNA input from FFPE or FNA samplesQuantideX NGS RNA Lung Cancer Brochure Download
  • Comprehensive coverage of fusion and exon skipping events important to NSCLC disease: Fusion targets (110) Exon skipping events (MET exon 14)
  • Detect other fusion events with 3’-5’ imbalances in: ALK, RET, ROS1, NTRK1 and PDGFRA
  • Includes mRNA gene expression markers (24)


*For Research Use Only. Not for use in diagnostic procedures.

Back To